Figure 1.

Schematic of the megakaryocyte/platelet studies. Schematic of studies beginning with CD34⁺ HPCs to in vitro megakaryocyte differentiation in the presence of inhibitors to then in vitro and in vivo studies of the resulting day 12 megakaryocytes and EV-PLPs. Megs, megakaryocytes.